4//SEC Filing
Kazmi Syed 4
Accession 0000886163-11-000017
CIK 0000886163other
Filed
Feb 21, 7:00 PM ET
Accepted
Feb 22, 11:53 AM ET
Size
11.3 KB
Accession
0000886163-11-000017
Insider Transaction Report
Form 4
Kazmi Syed
VP, Bus. Dev. & Strategic Plan
Transactions
- Award
Incentive Stock Option (right to buy)
2011-02-17$10.05/sh+7,513$75,506→ 7,513 totalExercise: $10.05Exp: 2021-02-17→ Common Stock (7,513 underlying) - Award
Common Stock
2011-02-17+3,000→ 15,396 total - Award
Non-Qualified Stock Option (right to buy)
2011-02-17$10.05/sh+2,487$24,994→ 2,487 totalExercise: $10.05Exp: 2021-02-17→ Common Stock (2,487 underlying) - Award
Non-Qualified Stock Option (right to buy)
2011-02-17$10.05/sh+30,000$301,500→ 30,000 totalExercise: $10.05Exp: 2011-02-17→ Common Stock (30,000 underlying)
Footnotes (2)
- [F1]Grant to reporting person of options, exercisable over a 4-year period measured from the date of grant, 12-1/2% after six months, then 1/48th of the Optioned Shares per month thereafter.
- [F2]The options vest upon satisfaction of certain performance criteria for the year ended December 31, 2011.
Documents
Issuer
LIGAND PHARMACEUTICALS INC
CIK 0000886163
Entity typeother
Related Parties
1- filerCIK 0001406049
Filing Metadata
- Form type
- 4
- Filed
- Feb 21, 7:00 PM ET
- Accepted
- Feb 22, 11:53 AM ET
- Size
- 11.3 KB